NSE: GLAND
GLAND PHARMA LIMITED
Price history
+27.77% over 3M
Performance
52-week range
Position in day range
GLAND stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Uptrend
50-DMA ₹2,682.48
RSI (14)
64
Neutral momentum
Volatility (ATR)
3.03%
Moderate
Close streak
1d down
Volume vs 20d avg
0.61x
From 52W high
-3.13%
Up from 52W low
+87.27%
Green days (20)
9/20
Monthly seasonality
Average monthly move for GLAND across the available price history.
Key statistics
Open
3,031
Day high
3,031
Day low
2,918.9
Prev close
2,946.9
Volume
3.69 L
Avg vol (20d)
6.02 L
52W high
3,042
52W low
1,573.6
GLAND quarterly results
All GLAND results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹1,800 cr
+19.6% YoY
Net profit
₹317 cr
+47.1% YoY
Operating profit
₹378 cr
+41.8% YoY
EPS
₹19.23
+47.0% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹1,800 cr | ₹378 cr | ₹317 cr | 21.0% | 17.6% | ₹19.23 | +47.1% | -13.6% |
| Q4 FY262026-03-31 | ₹1,743 cr | ₹404 cr | ₹367 cr | 23.2% | 21.0% | ₹22.26 | +96.6% | +40.2% |
| Q3 FY262025-12-31 | ₹1,695 cr | ₹327 cr | ₹261 cr | 19.3% | 15.4% | ₹15.87 | — | +21.3% |
| Q1 FY262025-06-30 | ₹1,506 cr | ₹267 cr | ₹215 cr | 17.7% | 14.3% | ₹13.08 | — | +15.5% |
| Q4 FY252025-03-31 | ₹1,425 cr | ₹252 cr | ₹187 cr | 17.7% | 13.1% | ₹11.32 | — | — |
| TTM (last 4 quarters) | ₹6,744 cr | ₹1,376 cr | ₹1,161 cr | 20.4% | 17.2% | ₹70.44 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
Gland Pharma Sees 3.6x Volume Spike After OFS / Stake Sale Update — Levels, Volumes and the Follow-Up to Track
Gland Pharma (GLAND) trades at ₹2,932.40, +24.50 (+0.84%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Why Gland Pharma Share Price Opens Gap-Down at ₹2,870.00 Today: the OFS / Stake Sale Trigger, Explained
Gland Pharma (GLAND) trades at ₹2,907.90, +39.50 (+1.36%). The ofs-/-stake-sale trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Latest market news
Canara Hsbc Life Ins Share Price Opens Gap-Down at ₹149.40: What Is Driving CANHLIFE Today, and the Levels That Matter
Canara Hsbc Life Ins (CANHLIFE) trades at ₹152.36, +2.87 (+1.88%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
IPOs Leads the Morning Market Talk on 11 September 2026, Policy And Macro Data and Mutual Funds Close Behind
The most-covered market themes in the morning session on 11 September 2026 — IPOs, policy and macro data, mutual funds — with our live numbers for each and links to the publishers running the story.
Vodafone Idea Share Price Drops 4.16% to ₹14.90: What Is Driving IDEA Today, and the Levels That Matter
Vodafone Idea (IDEA) trades at ₹14.90, -0.62 (-4.16%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Novartis India Share Price Hits 52-Week High, Up 9.96%: What Is Driving NOVARTIND Today, and the Levels That Matter
Novartis India (NOVARTIND) trades at ₹2,428.20, +241.80 (+9.96%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
NEPHROPLUS in Focus: Nephrocare Health Serv Share Price Opens Gap-Down at ₹733.10 on Rising Newsflow
Nephrocare Health Serv (NEPHROPLUS) trades at ₹747.25, +13.80 (+1.85%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Fino Payments Bank Opens Gap-Down at ₹137.90 — Should Investors Read This as a Trend or a One-Day Move?
Fino Payments Bank (FINOPB) trades at ₹139.65, +2.01 (+1.44%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Price and history data from NSE via Upstox. For information only, not investment advice.